ABSTRACT
The exponential growth of percutaneous coronary intervention (PCI) has in large part been due to expansion of the indications to include the procedure in patients with extensive coronary disease, multiple risk factors, older age and comorbidities. Improvement in PCI equipment, development of new interventional techniques, and availability of myocardial and systemic support techniques have all contributed to this growth. With these advances, patients once considered high risk for PCI are no longer considered high risk. This article reviews the complex coronary lesions challenges, various interventional and pharmacologic strategies for optimal results and novel technology.
Subject(s)
Angioplasty, Balloon, Coronary/methods , Coronary Artery Disease/therapy , Stents , Clinical Trials as Topic , Coronary Artery Bypass/methods , Coronary Artery Disease/pathology , Evidence-Based Medicine , Humans , Randomized Controlled Trials as Topic , Risk Assessment , Risk Factors , Saphenous Vein/transplantation , Treatment OutcomeSubject(s)
Cardiomyopathy, Hypertrophic/diagnosis , Myocardial Infarction/diagnosis , Adrenergic beta-Antagonists/therapeutic use , Aged, 80 and over , Cardiomyopathy, Hypertrophic/drug therapy , Coronary Angiography , Diagnosis, Differential , Electrocardiography , Female , Humans , Magnetic Resonance Imaging , Tomography, Emission-Computed, Single-PhotonABSTRACT
Chronic mesenteric ischemia is rare and commonly presents with abdominal pain and weight loss. Treatment options are limited to surgical or endovascular revascularization. In this report we describe in detail successful stent-supported angioplasty of a high-grade superior mesenteric artery stenosis utilizing a right brachial artery approach. A brief review of the literature is provided.
